A study showed that LAG-3 activation enhanced intra-tumoral Tregs activity, blocking improved T cells function and reactivating tumor-infiltrating CD8+ T cells (CD8+TIL) to eliminate tumor cells [47]. This evidence concerns the gene CD8A and neoplasm.